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Abstract
Background: Substance use disorders (SUDs) among people with HIV are both prevalent and problematic. The
Substance Abuse Treatment to HIV care project was funded to test the Implementation and Sustainment Facilitation
(ISF) strategy as an adjunct to the Addiction Technology Transfer Center (ATTC) strategy for integrating a motivational
interviewing-based brief intervention (MIBI) for SUDs within HIV community-based organizations.
Methods: Using a cluster-randomized, type 2 hybrid trial design, 39 HIV organizations were randomized to either
(1) ATTC (n = 19) or (2) ATTC + ISF (n = 20). Each HIV organization identified two staff members to be prepared
to implement the MIBI (N = 78). Subsequently, during the implementation phase, HIV organizations in each condition
randomized client participants (N = 824) to one of the two intervention conditions: usual care (UC; n = 415) or UC + MIBI
(n = 409). Both staff-level outcomes and client-level outcomes were examined.
Results: The ISF strategy had a significant impact on the implementation effectiveness (i.e., the consistency and the
quality of implementation; β = .65, p = .01) but not on time-to-proficiency (β = −.02) or level-of-sustainment (β = .09). In
addition, the ISF strategy was found to have a significant impact on the intervention effectiveness (the effectiveness of
the MIBI), at least in terms of significantly decreasing the odds (odds ratio = 0.11, p = .02) of clients using their primary
substance daily during follow-up.
Conclusion: The ISF strategy was found to be an effective adjunct to the ATTC strategy in terms of implementation
effectiveness and intervention effectiveness. It is recommended that future efforts to integrate the project’s MIBI for
SUD within HIV organizations use the ATTC + ISF strategy. However, given the ISF strategy did not have a significant
impact on level-of-sustainment, implementation research testing the extent to which the ATTC + ISF strategy can be
significantly enhanced through effective sustainment strategies is warranted.
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Plain language abstract
Substance use among people living with HIV is associated with increased mental health problems, worse medication
adherence, and worse HIV viral suppression. Increasing substance use-related services in HIV community-based
organizations is an important public health need. The Substance Abuse Treatment to HIV care project tested two
strategies for helping HIV organizations implement a brief intervention (BI) designed to motivate clients to decrease
their substance use. The project also tested if receiving a BI improved clients’ outcome. Two staff from each of the 39
participating organizations were taught how to deliver the BI using the Addiction Technology Transfer Center (ATTC)
training strategy (online and in-person training, monthly feedback, and coaching). Half of the organizations also received
the Implementation and Sustainment Facilitation (ISF) strategy, which included monthly meetings with an ISF coach for
the two BI staff and one or more leadership staff from the organization. Organizations that received both the ATTC
and ISF strategies delivered more BIs and higher quality BIs than organizations that only received the ATTC strategy. In
addition, clients receiving BIs at organizations that received both strategies were more likely to decrease their substance
use. However, receiving both strategies did not improve how quickly staff learned to deliver the BI or improve the
number of BIs delivered during the project’s 6-month sustainment phase. Future research focused on implementing BIs
within HIV organizations should consider using the ATTC and ISF strategies while also seeking to enhance the strategies
to improve sustainment.
Keywords
Implementation strategies, external facilitation, substance use, Addiction Technology Transfer Center, motivational
interviewing, HIV
Substance use among people with HIV is a significant
public health issue given it has been found to be associated
with increased psychiatric problems (Gaynes et al., 2008),
poorer HIV viral suppression (Arnsten et al., 2002; King
et al., 2009; Lucas et al., 2001), poorer HIV medication
adherence (Azar et al., 2010; Friedman et al., 2009;
Hendershot et al., 2009; Malta et al., 2008), and increased
likelihood of engaging in risk behaviors that result in
infection transmission to others (Hutton et al., 2019;
Palepu et al., 2003; Satre et al., 2020). Increasing its public
health significance further, research suggests approximately half of the people with HIV have a substance use
disorder (SUD) (Hartzler et al., 2017).
Complementing HIV primary care, HIV communitybased organizations (hereafter HIV organizations) provide
medical and non-medical case management services and
are a major source of care for people with HIV (U.S.
Department of Health and Human Services, Health
Resources and Services Administration, Bureau of Primary
Health Care, 2017). Thus, in 2014, as part of its effort to
help improve the integration of substance use services
within HIV service settings, the National Institute on Drug
Abuse funded the Substance Abuse Treatment to HIV care
project. The project’s primary aim was to test the
Implementation and Sustainment Facilitation (ISF) strategy as an adjunct to the Addiction Technology Transfer
Center (ATTC) strategy for helping HIV organizations and
their staff integrate a motivational interviewing-based
brief intervention (MIBI) for SUDs. Given the importance
of context (Aarons et al., 2011; Damschroder et al., 2009)
and given research on the effectiveness of MIBIs for SUDs
in HIV settings was limited (Aharonovich et al., 2006,
2012; Hasin et al., 2013), the project also examined the

impact of the ISF strategy on intervention effectiveness
(the effectiveness of the MIBI on improving client-level
outcomes) (Garner, Gotham, et al., 2017; Helfrich et al.,
2007; Klein et al., 2001; Klein & Sorra, 1996; Weiner
et al., 2009). Written in accordance with both the
Consolidated Standards of Reporting Trials (CONSORT)
guidelines for cluster-randomized trials (Campbell et al.,
2012) (see Supplemental File 1 for checklist) and the
Standards for Reporting Implementation Studies (StaRI)
guidelines (Pinnock et al., 2017) (see Supplemental File 2
for checklist), this article presents the main findings from
the project.

Rationale for trial design
We used a cluster-randomized design (HIV organizations
were the unit of randomization) to minimize the likelihood of
contamination across the project’s two implementation conditions and because cluster-randomized designs had been noted
as being preferred over other designs, including steppedwedge designs (Kotz et al., 2012a, 2012b; Mdege et al.,
2012). However, beyond the use of a cluster-randomized
design, we used a type 2 hybrid trial design given Curran
et al.’s (2012) recommendation of it as an innovative design
“in support of more rapid translation” and to “provide more
valid estimates of potential clinical effectiveness.”

Rationale for testing a MIBI for SUDs
as an adjunct to usual care within HIV
organizations
As highlighted by DiClemente et al. (2017), multiple
reviews have supported the efficacy and effectiveness of
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MIBIs for reducing alcohol use (Kaner et al., 2009; Lundahl
et al., 2010; McQueen et al., 2011; Stewart, 2012) and cannabis use (Baker et al., 2009, 2010; Dennhardt & Murphy,
2013; Lundahl et al., 2010). However, supporting our
rationale for integrating a MIBI for SUDs within HIV service settings was research conducted within HIV service
settings and found MIBIs can be effective for reducing
alcohol use (Aharonovich et al., 2006; Hasin et al., 2013)
and the use of other substances (Aharonovich et al., 2012).
To help maximize the external validity of the project
and its findings, we aimed to examine the effectiveness of
the project’s MIBI for SUD as an adjunct to usual care
(UC) within HIV organizations (UC + MIBI compared
with UC only). Regarding UC within HIV organizations,
we found standardized substance use screening was rare,
with it being even rarer for HIV organizations to employ
staff adequately trained to address substance SUDs.
Rather, we found UC for SUDs within HIV organizations
was primarily referral to treatment.

Rationale for testing the ISF strategy
as an adjunct to the ATTC strategy
The combination of staff training, performance feedback,
and coaching has been found to be one of the most effective strategies for helping prepare individuals to implement MIBIs with proficiency (Barwick et al., 2012;
Darnell et al., 2016; de Roten et al., 2013; Madson et al.,
2009, 2019; Martino, 2010; Miller et al., 2004). The ATTC
Network has long used this multifaceted strategy to help
addiction treatment organizations improve the integration
of motivational interviewing for SUDs. As such, the ATTC
strategy was identified as one of the most promising strategies for helping HIV organizations and their staff integrate
the project’s MIBI. However, given implementation and
sustainment are acknowledged as multilevel processes
(Aarons et al., 2011; Proctor et al., 2009), the ATTC strategy, which mostly focuses on individual staff training (i.e.,
staff-focused), was hypothesized to be necessary but not
sufficient. Thus, building upon research that identified
facilitation as a promising strategy (Baskerville et al.,
2012; Cully et al., 2012; Gustafson et al., 2013; Harvey
et al., 2002; Kauth et al., 2010; Kitson et al., 2008; Liddy
et al., 2011; Owen et al., 2013; Parchman et al., 2013;
Seers et al., 2012; Stetler et al., 2006), we aimed to test the
ISF strategy, which focuses on training the staff in MIBI
and the organization’s leadership (i.e., team-focused) to
support MIBI implementation.
As detailed by Garner, Zehner, et al. (2017), the ISF
strategy is a multifaceted strategy with facilitation as
the overarching approach, encompassing six additional
discrete strategies. Grounded in the theory of implementation effectiveness (Helfrich et al., 2007; Klein
et al., 2001; Klein & Sorra, 1996; Weiner et al., 2009),
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the ISF strategy seeks to improve implementation effectiveness (the consistency and the quality of implementation of the clinical intervention) and intervention
effectiveness (the clinical intervention’s effectiveness
in terms of improving client outcomes) through improving implementation climate (the extent to which implementation is expected, supported, and rewarded).
Guided by the Exploration-Preparation-ImplementationSustainment (EPIS) framework (Aarons et al., 2011),
we sought to expand the theory of implementation
effectiveness in two ways. Specifically, by examining
the extent to which the ISF strategy would help decrease
staff time-to-proficiency and increase staff level-of-sustainment. In addition, the ISF strategy was grounded in
motivational interviewing principles (Wagner &
Ingersoll, 2012), which is similar to how Kauth et al.
(2010) employed motivational interviewing techniques
as part of their multifaceted facilitation strategy for
improving the implementation of cognitive behavioral
therapy. Thus, as part of each ISF strategy meeting, the
ISF facilitator attempted to (1) engage the implementation team, (2) help focus the implementation team on
the project’s key goal(s), (3) help evoke from the implementation team’s pros and cons related to the project’s
key goal(s), and (4) help the implementation team plan
how best to achieve the project’s key goals and sustain
those achievements over time.

Primary aims and hypotheses
The primary aim of the project was to test the ISF strategy as
an adjunct to the ATTC strategy for helping HIV organizations and their staff integrate a MIBI for SUDs. Guided by
the theory of implementation effectiveness (Helfrich et al.,
2007; Klein et al., 2001; Klein & Sorra, 1996; Weiner et al.,
2009) and the EPIS framework (Aarons et al., 2011), we
hypothesized that the ISF strategy would have significant
impacts on three staff-level outcome measures (see Figure
1). In addition, as detailed by MacKinnon (2011), integrating
moderators into research design is important to understand
the generalizability by first examining the extent to which
there are any differential effects that would impede interpretation of a main effect. Thus, consistent with the decomposed-first strategy (Preacher et al., 2016), we started with
moderation-focused hypotheses to avoid biases associated
with conflated effects. We hypothesized that the impact of
the ISF strategy on these staff-level outcomes would be moderated by the components of the Consolidated Framework
for Implementation Research’s (CFIR) (Damschroder et al.,
2009) characteristics of individuals domain (prior experience
with motivational interviewing, personal recovery status)
and inner setting domain (implementation climate, implementation readiness, and leadership engagement). Finally,
we hypothesized that the ISF strategy would moderate the
effect of MIBI on client outcomes.
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Methods
Trial design
The trial design was a cluster-randomized, type 2 hybrid
trial. Following an exploration phase in which HIV organizations were recruited, HIV organizations (and their
staff) were randomized to one of the two strategies: (1) the
ATTC strategy or (2) the ATTC + ISF strategy. Following
randomization, the trial was deployed using a multiphase
design that included three 6-month phases corresponding
to the preparation, implementation, and sustainment
phases of the EPIS framework (Aarons et al., 2011).
During the implementation phase, HIV organizations
recruited and randomized client participants to one of the
two clinical intervention conditions: UC or UC + MIBI.
Institutional Review Board (IRB) approval and oversight
of all research activities were provided by RTI
International’s IRB.

Context
HIV organizations, located in 23 states and the District of
Columbia within the United States, provided the context
for the project.

Participants
Staff participants. To be eligible to participate, an HIV
organization was required to serve a minimum of 100 individuals living with HIV per year; have at least two staff
members willing to be prepared to implement a MIBI for
SUDs; and have at least one leadership staff member (e.g.,
supervisor, manager, director) willing to help ensure that
MIBI staff were given sufficient time to participate. There
were no exclusion criteria. Each collaborating HIV organization identified two staff to be prepared to implement the
MIBI as part of the project’s implementation phase and to
be recruited for participation in staff surveys. Each HIV
organization also identified one to three leadership staff to
be recruited for participation in staff surveys. After staff
provided informed consent, which was obtained electronically, staff completed surveys prior to randomization
(before the preparation phase), after the implementation
phase (Month 13), and after the sustainment phase (Month
19), and received a US$25 e-gift card per survey. For more
details, see the study protocol paper (Garner, Zehner,
et al., 2017).
Client participants. Client eligibility was assessed by HIV
organization staff through the project’s standardized
screener. Eligibility criteria included having been diagnosed with HIV; being above 18 years of age; and acknowledging the use of at least one substance in the past 28 days
with self-reported endorsement of two or more of the 11
Diagnostic and Statistical Manual of Mental Disorders
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(DSM-5) criteria (American Psychiatric Association,
2013) for SUD for that substance during the past 12 months.
An exclusion criterion was not being able to speak English, which was due to the project’s research staff and
MIBI proficiency raters being monolingual. Clients who
met eligibility criteria were recruited for study participation by one of the several trained HIV organization staff. It
was one of the two MIBI staff members from each HIV
organization who was trained to obtain written informed
consent, administer the baseline assessment, follow-up
locator form, and open the randomization envelope with
client participants. Each HIV organization was provided
compensation to cover staff time to complete these
research-related activities. Clients randomized to the
UC + MIBI condition received the MIBI at no cost. Clients received a US$20 gift card for completing the baseline assessment and US$20 for completing a 4-week
follow-up assessment administered by research staff
blinded to all condition assignments.

Implementation strategies
Complementing the comprehensive descriptions provided as part of the open-access study protocol paper
(Garner, Zehner, et al., 2017) and information provided at
www.ISFstrategy.org, Table 1 defines and specifies the
10 discrete strategies in the ATTC strategy, as well as the
7 discrete strategies in the ISF strategy. For the ATTC
strategy, the HIV organization’s two recipient MIBI staff
were given the opportunity to receive 12 months of MIBI
training and technical assistance: training (5-hr online
didactics and 2-day in-person workshop), performance
feedback (standardized feedback on one to three MIBIs
during the preparation phase and standardized feedback
on all MIBIs during the implementation phase), and consultation (up to three 1-hr individual consultation calls
during the preparation phase and monthly 1-hr group
consultation calls during the implementation phase).
Thus, the maximum possible dose of the ATTC strategy
was 30 hr per MIBI staff. For the ISF strategy, the HIV
organization’s recipient MIBI staff and leadership staff
were given the opportunity to receive 18 months of external facilitation led by one of the project’s ISF facilitators
(monthly virtual meetings lasting up to 60 min, up to two
in-person facilitation meetings lasting up to 6 hr each).
Thus, the maximum possible dose of the ISF strategy was
30 hr for each of the HIV organization’s staff working on
the project. To maximize the extent to which the ISF
strategy was implemented with consistency and quality,
the project’s lead developer of the ISF strategy trained
each ISF facilitator, reviewed randomly selected ISF session recordings (each virtual ISF facilitation meeting was
video-recorded for the quality assurance purposes), and
regularly supervised the ISF facilitators (no less than
monthly, usually weekly).
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Clinical interventions
UC consisted of referral to formal addiction treatment,
mutual help services, or both. Clients randomized to
UC + MIBI received the project’s 20- to 30-min MIBI for
SUD provided by one of the HIV organization’s prepared/
trained MIBI staff. The MIBI was designed to motivate
individuals living with HIV who have an SUD to change
their substance use by examining their reasons for change,
receiving feedback about common negative interactions of
substance use and HIV-related health issues, further developing the importance or confidence to reduce or stop their
primary substance use, and making a plan for change. For
more details, see the study protocol paper (Garner, Gotham,
et al., 2017).

Outcome measures
Organized by phase (preparation phase, implementation
phase, and sustainment phase), Table 2 details the stafflevel outcome measures (time-to-proficiency, implementation effectiveness, and level-of-sustainment) and
client-level outcome measures (days of primary substance use, number of substance-related problems, times
engaging in risky behaviors, days of substance use treatment, and days of medication non-adherence) collected.

Moderator measures
Table 3 details the staff-level measures (implementation
readiness, implementation climate, leadership engagement,
tension-for-change, motivational interviewing experience,
and personal recovery status) hypothesized to moderate the
impact of the ISF strategy on the staff-level outcomes.

Targeted sample size
The targeted sample size was estimated through power
analyses with Optimal Design Software (Raudenbush
et al., 2011). For analyses of staff-level outcomes, it was
estimated that 78 MIBI staff nested within 39 HIV organizations would provide 80% power to detect a statistically
significant (p < .05) difference for effect sizes .67 or
greater (Garner, Zehner, et al., 2017). For analyses of client-level outcomes, it was estimated that 1,872 clients,
nested within 78 MIBI staff members, nested within 39
HIV organizations would provide 80% power to detect a
statistically significant difference for effect sizes .20 or
greater (Garner, Gotham, et al., 2017).

Randomization sequence generation
For randomization of HIV organizations (the clusters),
each HIV organization was allocated to one of the two
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implementation strategy conditions (ATTC; ATTC + ISF)
through an urn randomization process (Stout et al.,
1994). Specifically, using survey data collected during
the exploration phase from HIV organization staff, seven
organizational-level factors (importance of substance
use screening, importance of brief intervention for substance use, innovation-value fit, implementation strategy-value fit, implementation climate for MIBI,
implementation readiness for MIBI, and implementation
effectiveness for MIBI) were entered into an urn randomization program (Charpentier, 2003) that optimized
the balance of the two implementation strategy conditions based on these factors.
During the project’s implementation phase, HIV organizations randomized client participants to one of the two
intervention conditions (UC; UC + MIBI) through a
blocked randomization sequence (blocking size of 6) generated through a blocked randomization program (Sealed
Envelope, n.d.). Within each participating HIV organization, each MIBI staff had a lock box containing 36 sequentially numbered tamper-evident security envelopes
containing a randomization slip indicating condition
assignment. The randomization envelope was opened in
front of the client participant. Staff updated a centralized
recruitment tracking log monitored multiple times per
week by research staff.

Blinding
It was not possible to blind HIV organizations and their
staff to the assigned implementation strategy condition,
but the project’s ATTC strategy staff and quality raters
were blinded to implementation strategy condition
assignment. In addition, it was not possible to blind HIV
organizations, their staff, or client participants to clinical
intervention condition assignment, but the project’s
research staff who conducted the follow-up assessments
were blinded to all condition assignments.

Statistical methods
Statistical analyses were conducted using an intention-totreat approach. Staff-level outcomes were approximately
normal, and within-site variation was close to zero. A
series of multilevel adjusted analyses was conducted, each
of which controlled for project cohort and was weighted
through a propensity score weight derived by regressing
implementation strategy condition assignment on staff
characteristics. The interaction between the implementation strategy condition assignment and each hypothesized
moderator was examined first, with main effects examined
as appropriate.
Client-level outcomes had strong floor effects (0 of
28 days) and/or strong ceiling effects (28 of 28 days), which
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led to bimodal u-shaped, j-shaped, or inverted j-shaped distributions. Given these non-normal distributions, linear
regression analyses were not appropriate. Rather, these
types of distributions are appropriately addressed using
zero-and-one inflated beta regression after data are transformed to a proportion scale (0 to 1). This model is a mixture model with three parts: a prediction of the probability
of the ceiling effect vs. other values (the ceiling effect), a
prediction of the mean for values in between, but not
including, the floor and ceiling effect (non-ceiling/nonfloor effect), and a prediction of the probability of the floor
effect vs. other values (the floor effect). We fit three-level
multilevel models to account for the nesting of client participants within MIBI staff and MIBI staff within HIV
organizations using the R package (Liu & Kong, 2015).
Each model was adjusted for the baseline value of the
respective outcome measure, client characteristics (i.e.,
age, White, male, heterosexual, transgender, married, high
school or higher, alcohol as primary substance, and engagement in HIV care), project cohort, randomization to
ATTC + ISF condition, randomization to UC + MIBI condition, and the cross-level interaction between ATTC + ISF
condition and UC + MIBI condition.

Results
Participant flow and recruitment
HIV organizations were recruited in three cohorts, each lasting 20 months from the randomization of HIV organizations

Figure 1. Aims and hypotheses.
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to the final data collection. The first cohort, in the central
United States, occurred from January 2015 through August
2016 and resulted in the recruitment of 14 HIV organizations, 28 MIBI staff, and 191 client participants. The second
cohort, in the western United States, occurred from January
2016 through August 2017 and resulted in the recruitment of
11 HIV organizations, 22 MIBI staff, and 300 client participants. The third cohort, in the eastern United States, occurred
from January 2017 through August 2018 and resulted in the
recruitment of 14 HIV organizations, 28 MIBI staff, and 333
clients. Figure 2 details the flow of HIV organizations, MIBI
staff, and client participants through the project’s preparation, implementation, and sustainment phases. Although
similar numbers of staff were recruited across conditions,
about twice as many clients were screened, enrolled, and
randomized within the ATTC + ISF condition.

Baseline characteristics
Table 4 presents baseline characteristics for MIBI staff
participants for the overall sample (N = 78) and each condition (ATTC = 38; ATTC + ISF = 40). Overall, MIBI staff
participants were 25–34 years of age (46%), female (71%),
Caucasian/White (62%), a graduate degree or higher
(50%), 12 months or less tenure with current HIV organization (35%), and intermediate motivational interviewing
experience or higher (53%).
Table 5 presents the baseline characteristics for client
participants for the overall sample (N = 824) and each

Note. ATTC = Addiction Technology Transfer Center; ISF = implementation and sustainment facilitation; MIBI = motivational interviewing-based brief
intervention; UC = usual care. Bolded lines indicate primary aim and hypotheses; thin line indicates other aim; and dashed lines indicate hypothesized
moderators.

Blended strategy
Specification regarding dose
ATTC strategy
 Dose—up to 30 hr (5 hr for
the online training course;
16 hr for the 2-day in-person
training workshop; 3 hr for
up to three 1-hr individual
consultation calls; and 6 hr
for up to six 1-hr group
consultation calls).

(Continued)

Discrete strategy (definition)
Specification regarding actor, action, action target, and temporality
Centralized technical assistance (develop and use a system to deliver technical assistance focused on implementation issues).
 Actor—regional ATTC (e.g., Mid-America, Northwest, Northeast).
 Action—the overarching discrete implementation strategy that encompasses the other discrete implementation strategies listed below.
 Action target—two MIBI staff per HIV organization.
 Temporality—the initial kickoff meeting should be within 1 month of completing the exploration phase.
Develop educational materials (develop and format guidelines, manuals, toolkits, and other supporting materials in ways that make it easier for stakeholders
to learn about the innovation and for clinicians to learn how to deliver the clinical innovation).
 Actor—regional ATTC (e.g., Mid-America, Northwest, Northeast).
 Action—the MIBI protocol manual, which provides information and knowledge about how the MIBI is intended to be implemented.
 Action target—two MIBI staff per HIV organization.
 Temporality—finalization of educational materials (e.g., MIBI protocol manual) should be prior to the initial kickoff meeting.
Develop and organize quality monitoring system (develop and organize systems and procedures that monitor clinical processes and/or outcomes for
quality assurance and improvement).
 Actor—regional ATTC (e.g., Mid-America, Northwest, Northeast).
 Action—a web-based system (sat2hivproject.org) that enables secure and efficient sharing of data relevant to the evidence-based practice preparation and
implementation process.
 Action target—two MIBI staff per HIV organization.
 Temporality—finalization of quality monitoring systems (i.e., sat2hivproject.org) should be prior to the initial kickoff meeting.
Develop tools for quality monitoring (develop, test, and introduce quality monitoring tools with inputs [e.g., measures] specific to the innovation being
implemented).
 Actor—regional ATTC (e.g., Mid-America, Northwest, Northeast).
 Action—the Independent Tape Rater Scale, which enables reliable and valid rating of the extent to which staff deliver the evidence-based practice with fidelity.
 Action target—two MIBI staff per HIV organization.
 Temporality—finalization of tools for quality monitoring (i.e., Independent Tape Rater Scale) should be prior to the initial kickoff meeting.
Distribute educational materials (distribute educational materials [e.g., manuals] in-person, by mail, and/or electronically).
 Actor—regional ATTC (e.g., Mid-America, Northwest, Northeast).
 Action—distribute professionally printed copies of the MIBI protocol manual to each MIBI staff.
 Action target—two MIBI staff per HIV organization.
 Temporality—distribute at the workshop training.
Conduct educational meetings (hold meetings targeted toward providers, administrators, other organizational stakeholders, and community, patient or
consumer, and family stakeholders to teach them about the clinical innovation).
 Actor—regional ATTC (e.g., Mid-America, Northwest, Northeast).
 Action—in-person and web-based meetings that enable direct interaction between the actors (ATTC) and targeted users of the evidence-based practice (MIBI
staff).
 Action target—two MIBI staff per HIV organization.
 Temporality—educational meetings should begin at least 3 months before the implementation phase begins.
Make training dynamic (vary the information delivery methods to cater to different learning styles and work contexts and shape the training in the innovation
to be interactive).
 Actor—regional ATTC (e.g., Mid-America, Northwest, Northeast).
 Action—incorporate standardized role plays that enable MIBI staff to practice with each other and that facilitate understanding of the evidence-based practice
from both staff and client perspectives.
 Action target—two MIBI staff per HIV organization.
 Temporality—should begin during the first contact.

Table 1. Discrete strategies included within the ATTC strategy and the ISF strategy.
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ISF strategy
 Dose—up to 30 hr (18 hr
for up to 18 monthly virtual
facilitation meetings lasting
up to 1 hr each; 12 hr for up
to two in-person facilitation
meetings lasting up to 6 hr
each).

Table 1. (Continued)

(Continued)

Audit and provide feedback (collect and summarize clinical performance data over a specified period and give data to clinicians and administrators in the
hopes of changing provider behavior).
 Actor—regional ATTC (e.g., Mid-America, Northwest, Northeast).
 Action—generate and email standardized feedback reports to MIBI staff using the standardized quality monitoring tool (i.e., Independent Tape Rater Scale).
 Action target—two MIBI staff per HIV organization.
 Temporality—should begin approximately 1–2 weeks following the end of the in-person educational training workshop.
Provide ongoing consultation (provide clinicians with continued consultation with an expert in the clinical innovation).
 Actor—regional ATTC (e.g., Mid-America, Northwest, Northeast).
 Action—phone-based individualized meetings that enable direct contact between the ATTC trainer and one MIBI staff.
 Action target—two MIBI staff per HIV organization.
 Temporality—should begin approximately 1–2 weeks following the end of the in-person educational training workshop.
Create a learning collaborative (develop and use groups of providers or provider organizations that will implement the clinical innovation and develop ways
to learn from one another to foster better implementation).
 Actor—regional ATTC (e.g., Mid-America, Northwest, Northeast).
 Action—web-based group meetings that enable direct contact between the ATTC trainer and a group of 10–14 MIBI staff, who can share lessons learned.
 Action target—two MIBI staff per HIV organization.
 Temporality—should begin approximately 3–4 weeks after the implementation phase begins.
External Facilitation (seek guidance from experts in implementation, including consultation with outside experts [e.g., university-affiliated faculty members,
quality improvement experts, and implementation professionals]).
 Actor—an individual with training and experience in assisting organizations with practice improvement and implementation efforts.
 Action—the overarching implementation strategy that encompasses the other discrete implementation strategies listed below.
 Action target—the HIV organization’s designated team of staff working on the project (two MIBI staff and two to four leadership staff).
 Temporality—the initial kickoff meeting should be held within 1 month of completing the exploration phase.
Develop tools for quality improvement (develop, test, and introduce quality improvement tools with inputs [e.g., measures] specific to the innovation being
implemented).
 Actor—an individual with training and experience in assisting organizations with practice improvement and implementation efforts.
 Action—Decisional Balance Exercise; Performance Review, Evaluation, and Planning Exercise; Implementation Climate Evaluation Exercise.
 Action Target—the HIV organization’s designated team of staff working on the project (two MIBI staff and two to four leadership staff).
 Temporality—finalization of tools for quality improvement should be prior to the initial kickoff meeting.
Organize implementation team meetings (develop and support teams of clinicians who are implementing the innovation and give them protected time to
reflect on the implementation effort, share lessons learned, and support one another’s learning).
 Actor—an individual with training and experience in assisting organizations with practice improvement and implementation efforts.
 Action—meetings that enable direct interaction between ISF staff and the HIV organization’s staff working on the project.
 Action target—the HIV organization’s designated team of staff working on the project (two MIBI staff and two to four leadership staff).
 Temporality—first implementation team meeting should be held within 1 month of completing the exploration phase.
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Identify and prepare champions (cultivate relationships with people who will champion the clinical innovation and spread the word of the need for it).
 Actor—an individual with training and experience in assisting organizations with practice improvement and implementation efforts.
 Action—learning about and engaging with the HIV organization’s staff working on the project.
 Action target—the HIV organization’s designated team of staff working on the project (two MIBI staff and two to four leadership staff).
 Temporality—identification and preparation of champions should begin during the process of organizing the initial implementation team meeting.
Assess for readiness and identify barriers (assess various aspects of an organization to determine its degree of readiness to implement, barriers that may
impede implementation, and strengths that can be used in the implementation effort).
 Actor—an individual with training and experience in assisting organizations with practice improvement and implementation efforts.
 Action—utilization of the ISF exercises described above.
 Action target—the HIV organization’s designated team of staff working on the project (two MIBI staff and two to four leadership staff).
 Temporality—assessments of readiness and identification of barriers should begin during the process of organizing the initial implementation team meeting.
Conduct local consensus discussions (include providers and other stakeholders in discussions that address whether the chosen problem is important and
whether the clinical innovation to address it is appropriate).
 Actor—an individual with training and experience in assisting organizations with practice improvement and implementation efforts.
 Action—completion of an in-person, stakeholder engagement and sustainment-planning meeting.
 Action target—the HIV organization’s designated team of staff working on the project (two MIBI staff and two to four leadership staff).
 Temporality—should be held as soon as possible after the first implementation month has been completed.
Conduct cyclical small tests of change (implement changes in a cyclical fashion using small tests of change).
 Actor—an individual with training and experience in assisting organizations with practice improvement and implementation efforts.
 Action—completion of study-act-plan-do cycles.
 Action target—the HIV organization’s designated team of staff working on the project (two MIBI staff and two to four leadership staff).
 Temporality—should begin as soon as necessary.

Note. See the study protocol paper (Garner, Zehner, et al., 2017) for justification of each discrete strategy. ATTC = Addiction Technology Transfer Center; ISF = implementation and sustainment facilitation; MIBI = motivational
interviewing-based brief intervention.

Table 1. (Continued)
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Note. Intervention effectiveness was assessed in terms of the impact of the ISF strategy on each of the client outcome measures. MIBI = motivational interviewing-based brief intervention; SUD = substance
use disorder; MI = motivational interviewing; DSM-5 = Diagnostic and Statistical Manual of Mental Disorders, 5th ed.

3.5. Days of HIV medication nonadherence
4. Level-of-sustainment (sustainment
phase)

3.4. Days of substance use treatment

3.3. Times engaging in risky behaviors

3.2. Number of substance-related
problems

3. Intervention effectiveness
(implementation phase) regarding:
3.1. Days of primary substance use

A client-level measure of the number of days client participants self-reported using their primary substance during the past 28 days and
measured using a modified version of the Addiction Severity Index (McLellan et al., 1992). Client’s primary substance was identified at
baseline by asking “Of the substances that you have used in the past 4 weeks (not including tobacco), which one has been the biggest
problem for you OR caused you the most problems?” At follow-up, client participants were reminded of the substance they had
indicated was their primary substance.
A client-level measure of the number of the 11 DSM-5 (American Psychiatric Association, 2013) SUD symptoms client participants selfreported recognition of regarding their primary substance and during the past 28 days. At follow-up, client participants were reminded of
the substance they had indicated was their primary substance.
A client-level measure of the number of times client participants self-reported engaged in unprotected sex, injection drug use, or needle
sharing during the past 28 days, which was developed for this project based on the Addiction Severity Index (McLellan et al., 1992).
A client-level measure of the number of days client participants self-reported having attended residential treatment, outpatient treatment,
or self-help group meetings during the past 28 days, which was developed for this project based on the Addiction Severity Index.
A client-level measure of the number of days client participants self-reported having missed at least one dose of their HIV medications
during the past 28 days, which was developed for this project based on the on the Addiction Severity Index (McLellan et al., 1992).
A staff-level measure of the number of MIBIs delivered during the project’s 6-month sustainment phase and measured through MIBI staff
self-report as part of the project’s sustainment phase survey.

A staff-level measure of the number of weeks between MIBI staff completing the in-person training and demonstrating proficiency in the
project’s MIBI for SUDs. Developed for this project based on research by Saldana (Saldana et al., 2012). Proficiency was determined by
one of the project’s MI experts, who rated audio recordings of MIBI practice sessions using the Independent Tape Rater Scale (Martino
et al., 2008). The Independent Tape Rater Scale is used to rate 10 MI-consistent items for adherence and competence along sevenpoint scales. MIBI proficiency was demonstrated when a single MIBI session had half the items rated at the mid-point or higher for both
adherence and competence items.
A staff-level measure of the overall consistency and the quality of MIBI implementation during the project’s implementation phase.
Developed for this project based on research by Klein et al. (2001). First, the cumulative number of MIBIs implemented was summed
and standardized for each MIBI staff (MIBI consistency). Second, the MIBI proficiency scores were summed and standardized for each
MIBI staff (MIBI quality). Proficiency of each MIBI session was assessed by the project’s cadre of raters who were trained, calibrated, and
supervised by one of the project’s MI experts. A quality score was calculated for each MIBI session by multiplying the corresponding
adherence rating (ranged from 1 to 7) and competence rating (ranged from 1 to 7) and summing for all 10 of the MI-consistent items
(ranged from 10 to 490). Finally, MIBI consistency and MIBI quality scores were summed and standardized.

1. Time-to-proficiency (preparation
phase)

2. Implementation effectiveness
(implementation phase)

Measure description

Measure name (phase)

Table 2. Outcome measures.
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Note. MIBI = motivational interviewing-based brief intervention; SUD = substance use disorder.

Tension-for-change

Leadership engagement

Implementation climate

A baseline measure of MIBI staff perception of their motivational interviewing experience. Measured by having MIBI staff, select one of the five response
options (none, beginner, intermediate, advanced, or expert).
A baseline measure indicating if MIBI staff considered themselves to be in recovery from alcohol/drugs (0 = no; 1 = yes).

Motivational
interviewing experience
Personal recovery
status
Implementation
readiness

A baseline measure representing MIBI staff perception regarding their organization’s readiness for implementing a brief intervention for SUDs.
Measured using the average of 12 items developed by Shea et al. (2014). Each item (e.g., staff working on this project want to implement this change;
staff working on this project are committed to implementing this change; staff working on this project will do whatever it takes to implement this
change) was measured on a five-point scale (1 = Disagree, 2 = Somewhat Disagree, 3 = Neither Agree nor Disagree, 4 = Somewhat Agree, 5 = Agree). Coefficient
alpha = .95.
A baseline measure representing MIBI staff perception regarding the extent to which implementing brief intervention for SUDs is expected, supported,
and rewarded within their organization. Measured using the average of the six items developed by Jacobs (Jacobs et al., 2014). Each item (e.g., staff
working on this project are expected to use brief intervention for substance use with a certain number of clients; staff working on this project get
the support they needed to use brief intervention for substance use with eligible clients; staff working on this project receive recognition for using
brief intervention for substance use with eligible clients) was measured on a five-point scale (1 = Disagree, 2 = Somewhat Disagree, 3 = Neither Agree nor
Disagree, 4 = Somewhat Agree, 5 = Agree). Coefficient alpha = .91.
A baseline measure representing MIBI staff perception regarding the extent to which their HIV organization leadership is committed, involved, engaged,
and accountable for implementing brief intervention for SUDs. Measured using the four items developed for this project based on the leadership
engagement construct described by Damschroder (Damschroder et al., 2009). Each item (to what extent was the leadership of this organization
committed to the implementation of brief intervention for substance use; to what extent was the leadership of this organization involved in the
implementation of brief intervention for substance use; to what extent was the leadership of this organization engaged in the implementation of brief
intervention for substance use; to what extent was the leadership of this organization accountable for the implementation of brief intervention for
substance use) was measured on seven-point scale (0 = not at all to 6 = highest extent possible). Coefficient alpha = .94.
A baseline measure representing MIBI staff perception regarding the extent to which implementing a brief intervention for SUDS is important,
needed, and desired. Measured using the three items developed for this project based on the tension-for-change construct described by Damschroder
(Damschroder et al., 2009). Each item (to what extent do staff working on this project believe implementation of brief intervention for substance use is
important; to what extent do staff working on this project believe implementation of brief intervention for substance use is needed; to what extent do
staff working on this project believe implementation of brief intervention for substance use is desired) was measured on seven-point scale (0 = not at all
to 6 = highest extent possible). Coefficient alpha = .92.

Measure description

Measure name

Table 3. Staff-level moderator measures.
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Figure 2. Participant flow.

Note. ATTC = Addiction Technology Transfer Center; IQR = interquartile range; ISF = implementation and sustainment facilitation; MIBI = motivational
interviewing-based brief intervention; UC = usual care.

condition (ATTC and UC = 134; ATTC and
UC + MIBI = 130; ATTC + ISF and UC = 281; ATTC + ISF
and UC + MIBI = 279). Overall, clients were male (76%),
African American/Black (54%), heterosexual (42%), a
high school graduate or higher (70%), and engaged in HIV
care (95%). Primary substance use for the overall sample
was alcohol (37%), cannabis (23%), cocaine/crack (18%),
methamphetamine (17%), heroin (2%), and other (3%).
On average, client participants reported using their primary substance 16 days during the past 28 days (57% of
days). However, 222 (27%) of client participants reported

using their primary substance daily during the past 28 days
(see Figure 3).

Implementation strategy dose
Regarding the ATTC strategy, the average dose (measured in
hours) per MIBI staff was 23.85 hr (SD = 1.62) for the ATTC
condition and 25.02 hr (SD = 1.63) for the ATTC + ISF condition. Regarding the ISF strategy, the average dose (also
measured in hours) was 9.29 hr (SD = 2.83) for MIBI staff
and 4.83 hr (SD = 3.09) for leadership staff.

Garner et al.
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Table 4. Staff characteristics at baseline.

Age (years)
18–24
25–34
35–44
45–54
55–64
Biological sex
Female
Male
Hispanic or Latino
Race
African American/Black
Asian
Caucasian/White
Graduate degree or higher
Experience in current profession (months)
<12
13–24
25–60
81–120
>121
Tenure at current organization (months)
<12
13–24
25–60
81–120
>121
Moderator measures
Intermediate MI experience or higher
In recovery for alcohol or drugs
Readiness for implementing change, M (SD)
Implementation climate, M (SD)
Leadership engagement, M (SD)
Tension-for-change, M (SD)

Overall (n = 78)

ATTC (n = 38)

ATTC + ISF (n = 40)

n

%

n

%

n

%

3
36
16
14
9

3.8
46.2
20.5
17.9
11.5

2
12
9
9
6

5.3
31.6
23.7
23.7
15.8

1
24
7
5
3

2.5
60.0
17.5
12.5
7.5

55
23
16

70.5
29.5
20.5

26
12
11

68.4
31.6
28.9

29
11
5

72.5
27.5
12.5

27
3
48
39

34.6
3.8
61.5
50.0

14
1
23
16

36.8
2.6
60.5
42.1

13
2
25
23

32.5
5.0
62.5
57.5

14
10
15
18
21

17.9
12.8
19.2
23.1
26.9

6
2
7
10
13

15.8
5.3
18.4
26.3
34.2

8
8
8
8
8

20.0
20.0
20.0
20.0
20.0

27
20
15
9
7

34.6
25.6
19.2
11.5
9.0

17
6
6
4
5

44.7
15.8
15.8
10.5
13.2

10
14
9
5
2

25.0
35.0
22.5
12.5
5.0

41
11
78
78
78
78

52.6
14.1
2.9 (1.4)
2.8 (1.1)
3.7 (1.7)
4.4 (1.4)

22
8
38
38
38
38

57.9
21.1
3.3 (1.4)
3.0 (1.1)
3.8 (1.6)
4.5 (1.3)

19
3
40
40
40
40

47.5
7.5
2.6 (1.4)
2.7 (1.1)
3.5 (1.7)
4.4 (1.4)

Note. ATTC = Addiction Technology Transfer Center; ISF = implementation and sustainment facilitation; MI = motivational interviewing; SD = standard
deviation.

Outcomes
Table 6 summarizes results of analyses focused on testing
the extent to which the ISF strategy had an impact on the
staff-level outcomes. Consistent with our hypotheses,
results of each moderator analysis are presented first, with
a main effect analysis reported as appropriate.
For time-to-proficiency, none of the hypothesized moderators were found to be significant. Furthermore, the ISF
strategy was not found to have a significant main effect on
decreasing time-to-proficiency, β = −.02, 95% confidence
interval (CI) = [−0.41, 0.37]. On average, time-to-proficiency
was 12.35 days (SD = 3.18) for MIBI staff in the ATTC condition and 11.44 days (SD = 4.87) for MIBI staff in the
ATTC + ISF condition.
For implementation effectiveness, none of the hypothesized moderators were found to be significant. However,

the ISF strategy was found to have a significant main
effect on increasing implementation effectiveness, β = .65,
95% CI = [0.25, 1.05], p < .01. On average, the sum number of MIBIs implemented during the implementation
phase (the consistency dimension of staff-level implementation effectiveness) was 3.32 (SD = 4.13) for MIBI
staff in the ATTC condition and 6.93 (SD = 5.49) for MIBI
staff in the ATTC + ISF condition. On average, the sum
quality score of MIBIs (the quality dimension of stafflevel implementation effectiveness) was 560 (SD = 780)
for MIBI staff in the ATTC condition and 1,324
(SD = 1,054) for MIBI staff in the ATTC + ISF condition.
For level-of-sustainment, none of the six hypothesized
moderators were found to be significant, and there was not
a significant main effect for the ISF strategy, β = .09, 95%
CI = [−0.42, 0.60]. On average, the number of MIBIs
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Table 5. Client characteristics at baseline.
Overall
(n = 824)

ATTC and UC
(n = 134)

ATTC and
UC + MIBI
(n = 130)

ATTC + ISF and
UC (n = 281)

ATTC + ISF
and UC + MIBI
(n = 279)

n

n

n

n

N

%

46
138
179
287
156
17

5.6
16.8
21.7
34.9
19.0
2.1

5
27
24
51
24
2

3.8
20.3
18.0
38.3
18.0
1.5

3
25
24
43
31
4

2.3
19.2
18.5
33.1
23.8
3.1

16
46
69
99
49
2

5.7
16.4
24.6
35.2
17.4
0.7

22
40
62
94
52
9

7.9
14.3
22.2
33.7
18.6
3.2

627
197

76.1
23.9

99
35

73.9
26.1

91
39

70.0
30.0

220
61

78.3
21.7

217
62

77.8
22.2

575
203
45
109

69.9
24.7
5.5
13.2

91
35
8
22

67.9
26.1
6.0
16.4

87
38
5
17

66.9
29.2
3.8
13.1

203
65
12
37

72.5
23.2
4.3
13.2

194
65
20
33

69.5
23.3
7.2
11.8

447
23

54.2
2.8

77
1

57.5
0.75

72
2

55.4
1.5

161
6

57.3
2.1

137
14

49.1
5.0

4
298
10

0.5
36.2
1.2

0
48
0

0.0
35.8
0.0

0
50
1

0
38.5
0.8

3
96
2

1.1
34.5
0.7

1
104
7

0.4
37.6
2.5

20

2.4

2

1.5

2

1.5

7

2.5

9

3.2

347
315
160
109
576
778

42.1
38.3
19.5
13.2
70.4
95.2

60
51
23
16
94
127

44.8
38.1
17.2
11.9
71.8
95.5

70
40
20
26
86
122

53.8
30.8
15.4
20.0
66.7
94.6

97
124
59
36
203
260

34.6
44.3
21.0
12.8
72.2
93.5

120
100
58
31
193
269

43.2
36.0
20.8
11.1
69.7
97.1

304
186
145
143
20
26

36.9
22.6
17.6
17.4
2.4
3.2

56
35
23
12
2
6

41.8
26.1
17.2
9.0
1.5
4.5

54
37
15
14
6
4

41.5
28.5
11.5
10.8
4.6
3.1

99
57
52
59
7
7

35.2
20.3
18.5
21.0
2.5
2.5

95
57
55
58
5
9

34.0
20.4
19.7
20.8
1.8
3.2

Outcome measures

N

M (SD)

n

M (SD)

n

M (SD)

n

M (SD)

n

M (SD)

Days of use
Problem recognition
Risky behaviors
Engagement in SUD treatment
Days of missed HIV medication

823
824
818
822
740

15.9 (9.7)
7.3 (3.1)
3.8 (9.8)
2.4 (7.1)
3.8 (6.3)

134
134
132
133
126

16.3 (9.8)
6.9 (3.1)
2.8 (10.7)
3.2 (8.5)
3.6 (6.2)

130
130
130
129
120

16.9 (9.9)
7.0 (3.2)
3.4 (7.5)
2.0 (6.5)
3.5 (5.8)

280
281
279
281
240

15.6 (9.7)
7.4 (3.2)
4.2 (11.2)
2.1 (7.5)
4.1 (6.4)

279
279
277
279
254

15.4 (9.5)
7.4 (3.1)
4.1 (8.7)
2.5 (6.2)
3.8 (6.4)

Age (years)
18–24
25–34
35–44
45–54
55–64
>65
Biological sex
Male
Female
Gender identity
Male
Female
Transgender
Hispanic or Latino
Race
African American/Black
 American Indian/Alaska
Native
Asian
Caucasian/White
 Native Hawaiian/Other
Pacific Islander
More than one
Sexual orientation
Heterosexual
Homosexual, gay, or lesbian
Other
Married
High school graduate or higher
Engaged in HIV care
Primary substance
Alcohol
Cannabis
Cocaine/crack
Methamphetamine
Heroin
Other

%

%

%

%

Note. ATTC = Addiction Technology Transfer Center; UC = usual care; MIBI = motivational interviewing-based brief intervention; ISF = implementation
and sustainment facilitation; SD = standard deviation; SUD = substance use disorder.
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Figure 3. Baseline distribution for client’s days of primary substance use.
Table 6. Moderator-first analyses of the impact of the ISF strategy on time-to-proficiency, implementation effectiveness, and levelof-sustainment.
Time-to-proficiency
(ICC = .22)
Estimate [95% CI]
MI experience
ATTC + ISF
MI experience (intermediate plus)
ATTC + ISF × MI experience
Personal recovery status
ATTC + ISF
In recovery
ATTC + ISF × in recovery
Implementation readiness
ATTC + ISF
Implementation readiness
 ATTC + ISF × implementation
readiness
Implementation climate
ATTC + ISF
Implementation climate
 ATTC + ISF × implementation
climate
Leadership Engagement
ATTC + ISF
Leadership engagement
 ATTC + ISF × leadership
engagement
Tension-for-change
ATTC + ISF
Tension-for-change
ATTC + ISF × Tension-for-change
Main effect
ATTC + ISF

Implementation effectiveness Level-of-sustainment
(ICC = .06)
(ICC = .001)
SE

p

Estimate [95% CI]

SE

p

Estimate [95% CI]

SE

p

−0.35 [−0.93, 0.23] 0.30 .24
−0.02 [−0.58, 0.54] 0.29 .95
0.63 [−0.14, 1.40] 0.39 .11

0.72 [0.12, 1.32] 0.30 .02 0.34 [−0.42, 1.10] 0.39 .39
0.21 [–0.37, 0.79] 0.30 .48 0.18 [−0.56, 0.92] 0.38 .64
–0.08 [–0.88, 0.72] 0.41 .85 −0.47 [−1.49, 0.55] 0.52 .37

0.09 [−0.33, 0.51] 0.21 .67
0.35 [−0.39, 1.09] 0.38 .35
−0.90 [−2.04, 0.24] 0.58 .13

0.72 [0.29, 1.15] 0.22 .00 0.26 [−0.28, 0.80] 0.28 .34
–0.01 [–0.77, 0.75] 0.39 .99 0.64 [−0.33, 1.61] 0.49 .20
–0.57 [–1.74, 0.60] 0.60 .35 −1.36 [−2.84, 0.12] 0.76 .08

0.43 [−0.53, 1.39] 0.49 .38
0.15 [−0.06, 0.36] 0.11 .16
−0.13 [−0.41, 0.15] 0.15 .36

–0.05 [–1.02, 0.92] 0.50 .92 −0.40 [−1.67, 0.87] 0.65 .54
–0.20 [–0.41, 0.01] 0.11 .06 −0.08 [−0.35, 0.19] 0.14 .58
0.21 [–0.08, 0.50] 0.15 .15 0.16 [−0.22, 0.54] 0.19 .41

0.20 [−0.93, 1.33] 0.58 .73
0.02 [−0.25, 0.29] 0.14 .86
−0.08 [−0.43, 0.27] 0.18 .67

0.67 [–0.48, 1.82] 0.59 .26 −0.56 [−2.04, 0.92] 0.75 .46
–0.05 [–0.32, 0.22] 0.14 .73 −0.15 [−0.50, 0.20] 0.18 .41
–0.01 [–0.37, 0.35] 0.18 .96 0.21 [−0.25, 0.67] 0.24 .37

0.18 [−0.82, 1.18] 0.51 .72
0.02 [−0.16, 0.20] 0.09 .84
−0.06 [−0.31, 0.19] 0.13 .66

0.04 [–0.98, 1.06] 0.52 .94 −0.53 [−1.84, 0.78] 0.67 .43
–0.12 [–0.30, 0.06] 0.09 .21 −0.03 [−0.26, 0.20] 0.12 .82
0.16 [–0.09, 0.41] 0.13 .20 0.17 [−0.15, 0.49] 0.16 .31

0.20 [−1.25, 1.65] 0.74 .79
−0.01 [−0.24, 0.22] 0.12 .93
−0.05 [−0.36, 0.26] 0.16 .76

0.07 [–1.41, 1.55] 0.75 .93 −0.30 [−2.21, 1.61] 0.97 .76
–0.01 [–0.25, 0.23] 0.12 .91 −0.10 [−0.40, 0.20] 0.16 .54
0.13 [–0.18, 0.44] 0.16 .41 0.08 [−0.32, 0.48] 0.21 .69

−0.02 [−0.41, 0.37] 0.20 .91

0.66 [0.26, 1.06]

0.20 .00

0.09 [−0.42, 0.60] 0.26 .74

Note. ISF = implementation and sustainment facilitation; ICC = intracluster correlation; CI = confidence interval; SE = standard error; MI = motivational
interviewing; ATTC = Addiction Technology Transfer Center.
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Table 7. Cross-level interactions examining the impact of the ISF strategy on the intervention effectiveness of the MIBI.
Days of primary
substance use
(ICC = .07)
OR [95% CI]
Ceiling effect
 UC + MIBI × 0.11 [0.08, 0.15]
ATTC + ISF
 ATTC + ISF 4.11 [3.25, 5.19]
 UC + MIBI
1.87 [1.44, 2.42]
Non-ceiling/ Non-floor effect
UC + MIBI × 1.03 [0.74, 1.43]
ATTC + ISF
ATTC + ISF 1.02 [0.81, 1.29]
UC + MIBI
1.09 [0.84, 1.41]
Floor effect
 UC + MIBI × 1.51 [1.09, 2.10]
ATTC + ISF
ATTC + ISF 2.00 [1.58, 2.53]
UC + MIBI
1.05 [0.81, 1.37]

Number of
Times engaging
substance-related
in risky behaviors
problems (ICC = .06) (ICC = .03)
p

OR [95% CI]

p

OR [95% CI]

p

Days of substance
use treatment
(ICC = .03)

Days of HIV
medication nonadherence (ICC = .01)

OR [95% CI]

OR [95% CI]

p

p

.02 0.26 [0.20, 0.36] .16

•

.04 6.68 [5.39, 8.28] .01
.39 1.50 [1.18, 1.91] .62

2.50 [2.07, 3.02] 0.50
0.36 [0.29, 0.45] 0.13

.87 0.86 [0.64, 1.16] .33 0.62 [0.36, 1.08] .10 1.39 [0.79, 2.44] .25 1.18 [0.90, 1.55] 0.23
.86 1.36 [1.09, 1.68] .01 1.02 [0.66, 1.56] .93 0.95 [0.65, 1.40] .81 1.09 [0.90, 1.32] 0.36
.53 1.05 [0.82, 1.33] .72 1.26 [0.78, 2.05] .35 0.72 [0.45, 1.15] .17 0.88 [0.70, 1.10] 0.25
.58 1.51 [1.12, 2.03] .73 0.91 [0.52, 1.59] .86 0.82 [0.47, 1.44] .62 0.89 [0.68, 1.17] 0.75
.20 0.85 [0.68, 1.05] .85 0.59 [0.39, 0.91] .15 1.40 [0.95, 2.05] .26 1.23 [1.01, 1.48] 0.45
.94 0.93 [0.74, 1.19] .94 1.08 [0.66, 1.74] .87 1.10 [0.69, 1.74] .78 1.14 [0.91, 1.43] 0.68

Note. • indicates variable removed to allow model to converge. Ceiling effects were excluded for outcomes without a ceiling effect. Times engaging in
risk behavior have no theoretical ceiling. Past 28 days substance use treatment does have an actual ceiling at 28, but it was so infrequently observed in
the data that a ceiling effect did not result. ISF = implementation and sustainment facilitation; MIBI = motivational interviewing-based brief intervention;
ICC = intracluster correlation; OR = odds ratio; CI = confidence interval; UC = usual care; ATTC = Addiction Technology Transfer Center.

Figure 4. Follow-up distribution for client’s days of primary substance use.

implemented during the sustainment phase was 3.42
(SD = 6.31) for MIBI staff in the ATTC condition and 3.18
(SD = 8.33) for MIBI staff in the ATTC + ISF condition.
Table 7 summarizes results of analyses focused on testing the extent to which the ISF strategy had an impact on
the effectiveness of the MIBI to improve client outcomes.

Consistent with our hypotheses, the cross-level interactions between implementation condition and clinical intervention condition are presented first, with the other key
terms presented below.
For days of primary substance use (see Figure 4 for
the distribution at follow-up), the ISF strategy had a
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Figure 5. The impact of the ISF strategy on intervention
effectiveness.
Note. ISF = implementation and sustainment facilitation.

significant impact on the effectiveness of the MIBI, at
least in terms of significantly decreasing the odds, (odds
ratio [OR] = 0.11, 95% CI = [0.08, 0.15], p = .01) of clients using their primary substance daily during the 28-day
follow-up period. To help interpret the size of this effect,
an OR of 0.11 is equivalent to an OR of 9.09 (1/0.11 = 9.09),
which is considered a large effect (Chen et al., 2010). The
ISF strategy increased the odds (OR = 1.51) of clients
being completely abstinent from their primary substance
at follow-up, but this small effect was not statistically
significant. Complementing the results shown in Table 7,
Figure 5 helps visualize the cross-level interaction
between implementation condition and intervention condition on days of primary substance use.
The ISF strategy was not found to have a significant
impact on the effectiveness of the MIBI for the other client
outcome measures. However, there were significant effects
for the ATTC + ISF strategy on clients’ endorsement of
problems related to their primary substance (problem recognition), which is important, yet distinct from the effectiveness of the MIBI (intervention effectiveness).
Specifically, the ATTC + ISF strategy increased the odds
of client participants endorsing that their primary substance was associated with each of the 11 DSM-5 symptoms (ceiling effect; OR = 6.68, 95% CI = [5.39, 8.28],
p = .01) and the number of the 11 DSM-5 symptoms
endorsed for client participants without a ceiling/floor
effect (OR = 1.36, 95% CI = [1.09, 1.68], p = .01).

Discussion
We used a cluster-randomized, type 2 hybrid trial to simultaneously test the impact of the ISF strategy (as an adjunct
to the ATTC strategy) on (1) the integration of a MIBI for
SUDs within HIV organizations across the United States
and (2) the effectiveness of the MIBI (as an adjunct to UC
within HIV organizations). Contributing to the growing
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literature on the effectiveness of facilitation-based strategies (Chinman et al., 2015, 2017; Jones et al., 2015;
Kilbourne et al., 2014, 2015; Kirchner et al., 2014; Lessard
et al., 2015; Liddy et al., 2015; Seers et al., 2018) and the
effectiveness of MIBIs for SUD within HIV service settings (Aharonovich et al., 2012, 2017; Haldane et al.,
2018; Hasin et al., 2014; Kahler et al., 2018; Scott-Sheldon
et al., 2017; Wray et al., 2016), we found at least two findings of significance. First, we found evidence that the ISF
strategy had a significant impact on improving the consistency and quality of MIBI implementation during the
implementation phase (implementation effectiveness).
Second, we found evidence that the ISF strategy had a significant impact on improving the effectiveness of the MIBI
(intervention effectiveness). However, our main findings
also included null results. Indeed, we did not find support
for our hypotheses that staff-level measures of the inner
setting domain (implementation readiness, implementation climate, leadership engagement, and tension-forchange) and characteristics of individuals domain
(motivational interviewing experience and personal recovery status), two of the key CFIR domains (Damschroder
et al., 2009), moderated the impact of the ISF strategy.
Although these measures were not found to moderate the
impact of the ISF strategy, we posit it remains possible one
or more of these measures may mediate (i.e., help explain)
the impact of the ISF strategy on implementation effectiveness, which has been explicitly hypothesized. As such,
subsequent mediational analyses are warranted. In addition, we did not find support for our hypotheses that the
ISF strategy would significantly decrease time-to-proficiency and significantly increase the level-of-sustainment.
Organized in chronological order along the EPIS continuum (Aarons et al., 2011), below we discuss the limitations, generalizability, and implications of our findings
(Campbell et al., 2012; Pinnock et al., 2017).
In terms of time-to-proficiency, we did not find evidence supporting our hypotheses. However, we believe
that the potential for the ISF strategy to decrease time-toproficiency was limited by requiring MIBI staff to demonstrate proficiency before they were allowed to help
implement/test the project’s MIBI for SUDs and/or
instructing MIBI staff to demonstrate MIBI proficiency
sometime before the beginning of the project’s implementation phase, rather than as soon as possible. As such, our
findings may or may not generalize to contexts in which
there is a stronger justification for staff demonstrating
MIBI proficiency as soon as possible (e.g., fee-for-service
contexts). In terms of implications, this finding advances
knowledge regarding the preparation of staff to implement
a MIBI for SUDs and highlights the need for research
experimentally testing the extent to which strategies minimize the time to complete key activities (Saldana et al.,
2012) and the extent to which the impact of these strategies is significantly moderated by constructs hypothesized
to be important (Damschroder et al., 2009).
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Consistent with our time-to-proficiency finding, we did
not find evidence to support our moderation-focused
hypotheses regarding the impact of the ISF strategy on
implementation effectiveness. We did, however, find evidence that the ISF strategy significantly improved the
average level of implementation effectiveness achieved by
MIBI staff. An early indicator of the impact of the ISF
strategy on this outcome was the finding that about twice
as many clients were screened, enrolled, and randomized
within the ATTC + ISF condition (see Figure 1). A potential limitation of this finding is that MIBI staff were asked
to limit the number of MIBIs implemented to three per
month. This was done to help increase the likelihood that
the monthly performance feedback and group consultation
provided as part of the ATTC strategy could have an impact
on MIBI quality, which is important given implementation
effectiveness is defined as the both the consistency (i.e.,
the number of MIBIs implemented) and quality (i.e., the
adherence and competence to the MIBI protocol) of implementation (Garner, Zehner, et al., 2017; Klein et al., 2001;
Klein & Sorra, 1996). Although we believe this approach
was well-justified, our findings may not generalize to less
controlled contexts or contexts in which the quality component of implementation effectiveness is not using the
Independent Tape Rater Scale to measure MIBI quality.
Nonetheless, a key implication of this finding is that the
ISF strategy was a promising adjunct to the ATTC strategy,
at least for improving the implementation of our project’s
MIBI for SUDs within HIV organizations. Thus, it is recommended that intermediary/purveyor organizations seeking to improve the integration of a MIBI for SUD within
HIV organizations, such as the AIDS Education and
Training Center network, consider use of the ATTC + ISF
strategy for such efforts.
Consistent with prior research highlighting that variation in implementation influences program outcomes
(Durlak & DuPre, 2008; Garner et al., 2016), we found
that in addition to significantly improving implementation effectiveness, the ISF strategy significantly improved
the intervention effectiveness. Notwithstanding the
importance of this finding, it is important to note that the
ISF strategy’s impact on the effectiveness of the project’s
MIBI for SUDs was limited to a single client outcome,
days of primary substance use. Unfortunately, less than
optimal recruitment and randomization of client participants, which has recently been highlighted as a key
potential drawback of type 2 hybrid trials (Landes et al.,
2019), limited our power to detect statistically significantly differences in the study’s other client outcome
measures. Other noteworthy limitations are that the days
of primary substance use and the other client outcome
measures were based on client self-report and limited to
a 4-week follow-up period. To the best of our knowledge,
we are the first to have experimentally tested the impact
of an implementation strategy on intervention effectiveness (i.e., the cross-level impact of an implementation
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strategy on the relative effectiveness of the experimental
clinical intervention compared to the control clinical
intervention), which is distinct from our prior implementation research that tested the impact of an implementation strategy on client outcomes (i.e., the direct impact of
the implementation strategy to improve client outcomes
relative to the control implementation strategy; Garner
et al., 2012). Thus, the generalizability of our findings
may need to be limited to contexts similar to our current
study. The key implication of this finding is that future
efforts to improve the integration of MIBIs for SUDs
within HIV organizations, both implementation research
and implementation practice, should consider the use of
the ATTC + ISF strategy. Finally, Foy et al. (2015) noted,
“If studies evaluating the effects of implementation intervention are to be of relevance to policy and practice, they
should have endpoints related to evidence-based processes of care, patient outcomes, or population outcomes.” Thus, another implication of our finding is the
need for more type 2 hybrid trials that enable tests of
impact on intervention effectiveness, which is arguably
one of the most relevant endpoints of all.
Although the level-of-sustainment is not possible without some level of implementation effectiveness occurring
first, the level-of-sustainment is another endpoint of significant relevance (Chambers et al., 2013; Proctor et al.,
2015; Stirman et al., 2012). Thus, it is significant to note
that we did not find support for our hypotheses related to
the level-of-sustainment, and the average level-of-sustainment was not only similar between conditions but was
also relatively low (only three MIBIs during the 6-month
sustainment period). The key limitation associated with
this finding is that level-of-sustainment was based on selfreport from MIBI staff. It does not appear that self-report
led to MIBI staff overestimating their level-of-sustainment. Our level-of-sustainment finding was also limited
by not being able to measure the extent to which MIBIs
were implemented with quality. Conservatively, the generalizability of our findings should be limited to efforts to
testing the impact of the ISF strategy as an adjunct to the
ATTC strategy or the level-of-sustainment of a MIBI for
SUDs within HIV organizations. However, we believe our
findings generalize more broadly to research that has
advanced knowledge regarding sustainment (Hunter
et al., 2015, 2017). Arguably, sustainment is one of the
most important outcomes to identify the effective strategies for, especially given that the lack of sustainment
minimizes the return-on-investments for resources
expended during prior phases along the EPIS continuum
(exploration phase, preparation phase, and implementation phase) (Aarons et al., 2011). Thus, a key implication
is that future research is needed to test strategies that can
significantly improve both the relative effectiveness of
the ATTC + ISF strategy on the level-of-sustainment and
the extent to which the ATTC + ISF strategy improves the
absolute level-of-sustainment.
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In conclusion, although the ATTC strategy was found to
be sufficient for the preparation of HIV organization staff
to implement a MIBI for SUDs, the ISF strategy was found
to be an effective adjunct to the ATTC strategy in terms of
both implementation effectiveness and intervention effectiveness. Based on these findings, future implementation
research and practice focused on integrating a MIBI for
SUD within HIV organizations should consider using the
ATTC + ISF strategy. However, given the ISF strategy did
not have a significant impact on the level-of-sustainment,
which was similarly low in both implementation conditions, we also conclude that future efforts should seek to
enhance the ATTC + ISF strategy through strategies
focused on improving the level-of-sustainment during the
sustainment phase.
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